Graybug Vision, Inc. and CalciMedica Inc. announced that they have entered into a definitive merger agreement to combine the companies in an all-stock transaction
Graybug is a California-based clinical stage biopharmaceutical company that develops drug delivery therapies for chronic vision-threatening eye diseases.